Have any questions?
+44 1234 567 890
Stefan Erfurt
Aktuelle Position: | Doktorand am Institut für Biochemie & Department für Nephrologie |
Fachbereich: | Institut für Biochemie |
Einrichtung: | Nephrologie UKB, IAG MMKE |
Adresse: |
Campus Brandenburg an der Havel
Haus 11, 2. OG, Raum 3.15
Hochstraße 29
14770 Brandenburg |
Telefon: | +49 3381 41-2676 |
E-Mail: | stefan.erfurt@mhb-fontane.de |
Forschung: | acute kidney injury (AKI) |
Publikationen
Meine besten 5 Publikationen:
-
Erfurt S, Lauxmann M, Asmus K, Oess S, Patschan D, Hoffmeister M. Serum Nostrin—A risk fac-tor of death, kidney replacement therapy and acute kidney disease in acute kidney injury. PLOS ONE. 11. April 2024;19(4):e0299131. DOI: 10.1371/journal.pone.0299131
-
Erfurt S, Hoffmeister M, Oess S, Asmus K, Patschan S, Ritter O, u. a. Soluble IL-33 receptor pre-dicts survival in acute kidney injury. Journal of Circulating Biomarkers. 6. Juni 2022;11:28–35. DOI: 10.33393/jcb.2022.2386
-
Patschan D, Erfurt S, Oess S, Lauxmann M, Patschan S, Ritter O, u. a. Biomarker-Based Predic-tion of Survival and Recovery of Kidney Function in Acute Kidney Injury. KBR. 9. Februar 2023;1–1. DOI: 10.1159/000528633
-
Erfurt S, Hoffmeister M, Oess S, Asmus K, Ritter O, Patschan S, u. a. Serum IL-33 as a biomarker in different diseases: useful parameter or much need for clarification? Journal of Circulating Bi-omarkers. 30. November 2021;10(1):20–5. DOI: 10.33393/jcb.2021.2327
-
Marahrens B, Amann K, Asmus K, Erfurt S, Patschan D. Renal replacement therapy-requiring acute kidney injury due to tubulointerstitial nephritis and uveitis syndrome: case report. Journal of Medical Case Reports. 20. Dezember 2021;15(1):629. DOI: 10.1186/s13256-021-03147-z